Canadian Task Force on Preventive Health Care

Selected References

Preventive Health Care, 2001 update: Screening
mammography among women aged 40–49 years at average risk of breast cancer

Prepared by Jolie Ringash, MD, MSc, FRCP(C), Princess Margaret Hospital-University Health Network/University of Toronto, Ontario

These recommendations were finalized by the Task Force in August 1999

  1. National Cancer Institute of Canada. Canadian cancer statistics 1999. Toronto: The Institute; 1999.
  2. Miller AB, Howe GR, Wall C. The National Study of Breast Cancer Screening Protocol for a Canadian randomized controlled trial of screening for breast cancer in women. Clin Invest Med 1981;4(3-4):227-58.
  3. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. CMAJ 1992;147(10):1459-76.
  4. Morrison BJ. Screening for breast cancer. In: Canadian Task Force on the Periodic Health Examination. The Canadian guide to clinical preventive health care. Ottawa: Canada Communications Group; 1994. p. 788-95.
  5. Bjurstam N, Bjorneld L, Duffy SW, Smith TC, Cahlin E, Eriksson O, et al. The Gothenburg Breast Screening Trial: first results on mortality, incidence, and mode of detection for women ages 39–49 years at randomization. Cancer 1997;80(11):2091-9.
  6. Andersson I, Janzon L. Reduced breast cancer mortality in women under age 50: updated results from the Malmo Mammographic Screening Program. J Natl Cancer Inst Monogr 1997;(22):63-7.
  7. Hendrick RE, Smith RA, Rutledge JH III, Smart CR. Benefit of screening mammography in women aged 40–49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 1997;(22):87-92.
  8. Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000;355:129-34.
  9. AACR comments on mammography screening for women age 40 to 49. Oncology (Huntingt) 1997;11(3):368.
  10. National Institutes of Health Consensus Development Panel. National Institutes of Health Consensus Development Conference statement: breast cancer screening for women ages 40–49, January 21–23, 1997. J Natl Cancer Inst 1997;89(14):1015-26.
  11. Leitch AM, Dodd GD, Costanza M, Linver M, Pressman P, McGinnis L, et al. American Cancer Society guidelines for the early detection of breast cancer: update 1997. CA Cancer J Clin 1997;47(3):150-3.
  12. National Cancer Advisory Board issues mammography screening recommendations. 1997. Bethesda: National Cancer Advisory Board; 1997. (accessed 2000 Dec 21).
  13. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988;318(26):1728-33.
  14. Woolf SH, Battista RN, Anderson GM, Logan AG, Wang E. Assessing the clinical effectiveness of preventive maneuvers: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. A report by the Canadian Task Force on the Periodic Health Examination. J Clin Epidemiol
    1990;43(9):891-905.
  15. Shapiro S, Strax P, Venet L. Evaluation of periodic breast cancer screening with mammography. Methodology and early observations. JAMA 1966;195(9):731-8.
  16. Shapiro S, Venet W, Strax P, Venet L, Roeser R. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982;69(2):349-55.
  17. Shapiro S. Evidence on screening for breast cancer from a randomized
    trial. Cancer 1977;39(Suppl 6):2772-82.
  18. Shapiro S. Periodic screening for breast cancer: the HIP Randomized Controlled Trial. Health Insurance Plan. J Natl Cancer Inst Monogr 1997;(22):27-30.
  19. Andersson I, Andren L, Hildell J, Linell F, Ljungqvist U, Pettersson H. Breast cancer screening with mammography: a population-based, randomized trial with mammography as the only screening mode. Radiology 1979;132(2):273-6.
  20. Andersson I, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, et al. Mammographic screening and mortality from breast cancer: the Malmo Mammographic Screening Trial. BMJ 1988;297:943-8. 
  21. Tabar L, Gad A. Screening for breast cancer: the Swedish trial. Radiology 1981;138(1):219-22.
  22. Fagerberg G, Baldetorp L, Grontoft O, Lundstrom B, Manson JC, Nordenskjold B. Effects of repeated mammographic screening on breast cancer stage distribution. Results from a randomised study of 92934 women in a Swedish county. Acta Radiol Oncol 1985;24(6):465-73.
  23. Tabar L, Fagerberg G, Duffy SW, Day NE. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health 1989;43(2):107-14.
  24. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992;30(1):187-210.
  25. Tabar L, Chen HH, Fagerberg G, Duffy SW, Smith TC. Recent results from the Swedish two-county trial: the effects of age, histologic type, and mode of detection on the efficacy of breast cancer screening. J Natl Cancer Inst Monogr 1997;(22):43-7.
  26. Duffy SW, Tabar L, Fagerberg G, Gad A, Grontoft O, South MC, et al. Breast screening, prognostic factors and survival: results from the Swedish two county study. Br J Cancer 1991;64(6):1133-8.
  27. Roberts MM, Alexander FE, Anderson TJ, Forrest AP, Hepburn W, Huggins A, et al. The Edinburgh randomised trial of screening for breast cancer: description of method. Br J Cancer 1984;50(1):1-6.
  28. Alexander FE, Anderson TJ, Brown HK, Forrest AP, Hepburn W, Kirkpatrick AE, et al. The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer 1994;70(3):542-8.
  29. Alexander FE, Anderson TJ, Brown HK, Forrest AP, Hepburn W, Kirkpatrick AE, et al. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening . Lancet 1999;353(9168):1903-8.
  30. Alexander F, Roberts MM, Lutz W, Hepburn W. Randomisation by cluster and the problem of social class bias. J Epidemiol Community Health 1989;43(1):29-36.
  31. Baines CJ. Impediments to recruitment in the Canadian National Breast Screening Study: response and resolution. Control Clin Trials 1984;5(2):129-40.
  32. Mettlin CJ, Smart CR. The Canadian National Breast Screening Study. An appraisal and implications for early detection policy. Cancer 1993;72(4 Suppl):1461-5.
  33. Kopans DB, Halpern E, Hulka CA. Statistical power in breast cancer screening trials and mortality reduction among women 40–49 years of age with particular emphasis on the National Breast Screening Study of Canada. Cancer 1994;74(4):1196-203.
  34. Tarone RE. The excess of patients with advanced breast cancer in young women screened with mammography in the Canadian National Breast Screening Study. Cancer 1995;75(4):997-1003.
  35. Bailar JC III, MacMahon B. Randomization in the Canadian National Breast Screening Study: a review for evidence of subversion. CMAJ 1997;156(2):193-9.
    36.
  36. Cohen MM, Kaufert PA, MacWilliam L, Tate RB. Using an alternative data source to examine randomization in the Canadian National Breast Screening Study. J Clin Epidemiol 1996;49(9):1039-44.
  37. Baines CJ. A different view on what is known about breast screening and the Canadian National Breast Screening Study. Cancer 1994;74(4):1207-11.
  38. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study: update on breast cancer mortality. J Natl Cancer Inst Monogr 1997;(22):37-41.
  39. Baines CJ, To T, Wall C. Women's attitudes to screening after participation in the National Breast Screening Study. A questionnaire survey. Cancer 1990;65(7):1663-9.
  40. Frisell J, Glas U, Hellstrom L, Somell A. Randomized mammographic screening for breast cancer in Stockholm. Design, first round results and comparisons. Breast Cancer Res Treat 1986;8(1):45-54.
  41. Frisell J, Eklund G, Hellstrom L, Glas U, Somell A. The Stockholm Breast Cancer Screening Trial: 5-year results and stage at discovery. Breast Cancer Res Treat 1989;13(1):79-87.
  42. Frisell J, Lidbrink E. The Stockholm Mammographic Screening Trial: risks and benefits in age group 40–49 years. J Natl Cancer Inst Monogr 1997;(22):49-51.
  43. L'Abbe KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Ann Intern Med 1987;107(2):224-33.
  44. Smart CR, Hendrick RE, Rutledge JH, Smith RA. Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials. Cancer 1995;75(7):1619-26.
  45. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography. A meta-analysis . JAMA 1995;273(2):149-54.
  46. Glasziou PP, Woodward AJ, Mahon CM. Mammographic screening trials for women aged under 50. A quality assessment and meta-analysis. Med J Aust 1995;162(12):625-9.
  47. Report of the Organising Committee and Collaborators Falun Meeting. Breast-cancer screening with mammography in women aged 40–49 years. Swedish Cancer Society and the Swedish National Board of Health and Welfare. Int J Cancer 1996;68(6):693-9.
  48. Kerlikowske K. Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit. J Natl Cancer Inst Monogr 1997;(22):79-86.
  49. Glasziou P, Irwig L. The quality and interpretation of mammographic screening trials for women ages 40–49. J Natl Cancer Inst Monogr 1997;(22):73-7.
  50. De Koning HJ. Assessment of nationwide cancer-screening programmes. Lancet 2000;355:80-1.
  51. Miller AB, Baines CJ, To T, Wall C. Screening mammography re-evaluated. Lancet 2000;355:747.
  52. Duffy SW, Tabar L. Screening mammography re-evaluated. Lancet 2000;355:747-8.
  53. Moss S, Blanks R, Quinn MJ. Screening mammography re-evaluated. Lancet 2000;355(9205):748.
  54. Nystrom L. Screening mammography re-evaluated. Lancet 2000;355:748-9.
  55. Hayes C, Fitzpatrick P, Daly L, Buttimer J. Screening mammography re-evaluated. Lancet 2000;355:749.
  56. Law M, Hackshaw A, Wald N. Screening mammography re-evaluated. Lancet 2000;355:749-50.
  57. Cates C, Senn S. Screening mammography re-evaluated. Lancet 2000;355:750.
  58. Feig SA, Hendrick RE. Radiation risk from screening mammography of women aged 40–49 years. J Natl Cancer Inst Monogr 1997;(22):119-24.
  59. Dewar JA, Benhamou S, Benhamou E, Arriagada R, Petit JY, Fontaine F, et al. Cosmetic results following lumpectomy, axillary dissection and radiotherapy for small breast cancers. Radiother Oncol 1988;12(4):273-80.
  60. Taylor ME, Perez CA, Halverson KJ, Kuske RR, Philpott GW, Garcia DM, et al. Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys 1995;31(4):753-64.
  61. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998;338(16):1089-96.
  62. Lerman C, Trock B, Rimer BK, Boyce A, Jepson C, Engstrom PF. Psychological and behavioral implications of abnormal mammograms.Ann Intern Med 1991;114(8):657-61.
  63. Lerman C, Trock B, Rimer BK, Jepson C, Brody D, Boyce A. Psychological side effects of breast cancer screening. Health Psychol 1991;10(4):259-67.
  64. Walker LG, Cordiner CM, Gilbert FJ, Needham G, Deans HE, Affleck IR, et al. How distressing is attendance for routine breast screening? Psychooncology 1994;3(4):299-304.
  65. Fletcher SW. Breast cancer screening among women in their forties: an overview of the issues. J Natl Cancer Inst Monogr 1997;(22):5-9.
  66. Olivotto IA, Kan L, Coldman AJ. False positive rate of screening mammography. N Engl J Med 1998;339(8):560.
  67. Steggles S, Lightfoot N, Sellick SM. Psychological distress associated with organized breast cancer screening. Cancer Prev Control 1998;2(5):213-20.
  68. Sutton S, Saidi G, Bickler G, Hunter J. Does routine screening for breast cancer raise anxiety? Results from a three wave prospective study in England. J Epidemiol Community Health 1995;49(4):413-8.
  69. Swanson V, McIntosh IB, Power KG, Dobson H. The psychological effects of breast screening in terms of patients' perceived health anxieties. Br J Clin Pract 1996;50(3):129-35.
  70. Lightfoot N, Steggles S, Wilkinson D, Bissett R, Bakker D, Thoms J, et al. The short-term psychological impact of organized breast screening. Current Oncol 1994;1:206-11.
  71. Cockburn J, Staples M, Hurley SF, De Luise T. Psychological consequences of screening mammography. J Med Screen 1994;1(1):7-12.
  72. Bull AR, Campbell MJ. Assessment of the psychological impact of a breast screening programme . Br J Radiol 1991;64(762):510-5.
  73. Ellman R, Angeli N, Christians A, Moss S, Chamberlain J, Maguire P. Psychiatric morbidity associated with screening for breast cancer. Br J Cancer 1989;60(5):781-4.
  74. Harris R. Variation of benefits and harms of breast cancer screening with age. J Natl Cancer Inst Monogr 1997;(22):139-43.
  75. Reynolds T. British trial aims to settle mammography questions. J Natl Cancer Inst 1995;87(5):338-41.
  76. Eckhardt S, Badellino F, Murphy GP. UICC meeting on breast-cancer screening in pre-menopausal women in developed countries. Cancer 1994;73(3):745-9.

Link to Full Text of this review

Link to Structured Abstract of this review

Link to Summary Table of Recommendations of this review

Link to 2001 Update: Breast Self-Examination to Screen for Breast Cancer

Link to 1999 Update: Follow-up after breast cancer

Link to 1998 rewording of recommendation for screening women aged 50-59 for breast cancer

Link to 1994 Chapter: Screening for breast cancer

Top of Page

Home PageCTFPHC Home Page

Reprinted in modified format by the Canadian Task Force on Preventive Health Care
with permission.
Original Copyright © 1999 Minister of Supply and Services Canada.
For any technical issues please contact: webmaster@ctfphc.org
Last modified: February 20, 2001.